NCT03628703View on ClinicalTrials.gov

Response Inhibition in Tourette Syndrome

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 22, 2019

Primary Completion Date

June 30, 2023

Study Completion Date

March 15, 2024

Conditions
Tourette Syndrome
Interventions
DEVICE

Repetitive TMS

Repetitive Intermittent Theta-Burst Transcranial Magnetic Stimulation over the right Pre-supplementary Motor Area

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT03628703 - Response Inhibition in Tourette Syndrome | Biotech Hunter | Biotech Hunter